©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
Catabolite Inactivation of Fructose-1,6-bisphosphatase of Saccharomyces cerevisiae
DEGRADATION OCCURS VIA THE UBIQUITIN PATHWAY (*)

(Received for publication, August 8, 1995)

Stefan M. Schork Michael Thumm Dieter H. Wolf (§)

From the Institut für Biochemie, Universität Stuttgart, Pfaffenwaldring 55, Stuttgart D-70569, Germany

ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES

ABSTRACT

Catabolite inactivation of fructose-1,6-bisphosphatase (FBPase), a key enzyme in gluconeogenesis, is due to phosphorylation and subsequent degradation in the yeast Saccharomyces cerevisiae. The degradation process of the enzyme had been shown to depend on the action of the proteasome. Here we report that components of the ubiquitin pathway target FBPase to proteolysis. Upon glucose addition to yeast cells cultured on nonfermentable carbon sources FBPase is ubiquitinated in vivo. A multiubiquitin chain containing isopeptide linkages at Lys of ubiquitin is attached to FBPase. Formation of a multiubiquitin chain is a prerequisite for the degradation of FBPase. Catabolite degradation of FBPase is dependent on the ubiquitin-conjugating enzymes Ubc1, Ubc4, and Ubc5. The 26 S proteasome is involved in the degradation process.


INTRODUCTION

Specific and rapid degradation of certain proteins is a fundamental mechanism in many biological processes, including embryonic development, cell proliferation, cell cycle control, and metabolic regulation(1) . The pathways signaling selective proteolysis are only very poorly understood. The regulation of FBPase, (^1)a key enzyme in gluconeogenesis, represents an ideal model to study such signaling pathways. The cytoplasmic enzyme is subject to catabolite inactivation in the yeast Saccharomyces cerevisiae(2) . Addition of glucose to yeast cells grown on a nonfermentable carbon source causes a rapid inactivation of FBPase due to phosphorylation and subsequent degradation(3, 4, 5) . Since its discovery(6) , the proteolytic mechanism of FBPase degradation had remained elusive. The prominent proteolytic activities of the vacuole, especially proteinase yscB, in degrading FBPase in vitro at first suggested this lysosomal enzyme to be the catalyst of FBPase degradation under catabolite inactivation conditions(7) . However, experiments using mutants defective in the activity of proteinase yscB and other vacuolar proteases seemed to rule out this possibility(8, 9, 10) . Recently, selective uptake of FBPase into the vacuole and degradation by vacuolar proteases under catabolite inactivation conditions had been proposed(11) . However, mutants defective in proteolytic activities of the yeast proteasome revealed the involvement of this protease complex in glucose-induced degradation of FBPase, indicating this process to be a cytoplasmic event(12, 13) . 26 S proteasomes are large multicatalytic protease complexes located in the cytoplasm and nucleus of the eukaryotic cell. The 26 S proteasome is build up from a 20 S proteasome core and two additional 19 S subcomplexes(14, 15) . Proteasome mutants demonstrated the involvement of the enzyme complex in stress-dependent and ubiquitin-mediated proteolysis(16, 17, 18) . In vitro studies demonstrated that 26 S proteasomes rather than 20 S proteasomes are able to degrade ubiquitinated proteins in an ATP-dependent fashion(19, 20, 21) .

In eukaryotes the ubiquitin system constitutes the major cytoplasmic pathway targeting proteins to selective degradation(22, 23, 24, 25, 26) . Ubiquitin, a 76-residue polypeptide found in all eukaryotes, is covalently attached with its carboxyl-terminal glycine to the protein substrate through an isopeptide bond in a multistep reaction. Ubiquitin is first activated through the formation of a thiol ester bond of the carboxyl-terminal glycine with the ubiquitin-activating enzyme E1. Thereafter ubiquitin is transferred to a ubiquitin-conjugating enzyme E2, which subsequently links it to the -amino group of an internal lysine of the substrate protein. In some cases this last step is performed with the support of a ubiquitin ligase E3, which mediates the recognition of the target protein together with the E2 enzyme. In further successive reactions ubiquitin moieties are linked to the Lys residue of each previously conjugated ubiquitin molecule until a polyubiquitin chain is formed(27) . The specificity of the ubiquitin system for a certain substrate is thought to be a property of the E2 and E3 enzymes.

In yeast, 10 UBC (E2) genes have been identified until now (23) . UBC1, UBC4, and UBC5 encode a functionally overlapping group of enzymes, which mediate bulk turnover of short-lived and abnormal proteins(28, 29) . The UBC6 gene product resides in the endoplasmic reticulum membrane and seems to be involved in degradation of endoplasmic reticulum membrane proteins (30) . UBC3 (CDC34) and UBC9 encode genes required for degradation of cyclins and regulation of the cell cycle(31, 32) . The UBC2 (RAD6) gene is involved in different processes including DNA repair and protein degradation via the N-end rule pathway(33, 34) . The UBC10 (PAS2) gene product is essential for the biogenesis of peroxisomes(35) . UBR1 is the only gene encoding an E3 enzyme that has been identified in yeast as yet(36) .

Only a few in vivo substrates have been known up to now, which are targeted to degradation by the ubiquitin system. They include the yeast transcriptional regulators Matalpha2 (37) and GCN4(38) , cyclins(33, 39, 40, 41) , and the oncogene products p53 (42) and Mos (43) .

Another system rendering proteins susceptible to specific degradation via the proteasome is antizyme. Its function in the degradation of the tightly controlled ornithine decarboxylase has been shown in vitro and in vivo(44, 45) .

The signal rendering FBPase accessible to proteolysis through the proteasome during the catabolite inactivation process had remained unknown. Here we show that glucose-induced degradation of FBPase is signalled via the ubiquitin pathway.


MATERIALS AND METHODS

Plasmids

YEp96 is a 2-µm S. cerevisiae-Escherichia coli-based shuttle vector that encodes a synthetic version of yeast ubiquitin (Ub) under the control of the copper-inducible CUP1 promotor. YEp110 is identical to YEp96, with the difference that instead of wild-type Ub it encodes yeast Ub with an arginine (instead of lysine) at amino acid position 48 (Ub-R48). YEp112 codes for yeast Ub with an epitope from the hemagglutinin (ha) of influenza virus attached to the amino terminus (haUb). Except for this modification, the plasmid is also identical to YEp96. The plasmids used for expression of the different ubiquitin variants were a gift from M. Hochstrasser(46) .

Strains and Media

For overexpression of the different Ub variants, the S. cerevisiae wild-type strain W3031B (MATalpha ade2-1 leu2-3 -112 his3-11,15 trp1-1 ura3-1) and the FBPase deletion mutant strain W3031B-K0 (MATalpha ade2-1 leu2-3 -112 his3-11 trp1-1 ura3-1 fbp1::LEU2) were transformed with plasmid YEp96, YEp110, or YEp112, respectively. Both strains were a gift from H.-L Chiang(11) . Ubc mutant strains used in this study are congenic to wild-type strain YW01 (MATalpha lys2-801 leu2-3, 2-112 ura3-52 his3-200 trp1-1(am)). YW09: ubc1::URA3; YW013: ubc4::HIS3; YW017: ubc5::LEU2; YW023: ubc4::HIS3, ubc5::LEU2. The strains were a gift from S. Jentsch(28, 29) . Strain CMY762 (MATacim3-1 ura3-52 leu2Delta1 his3Delta-200) and congenic wild-type strain YPH499 were gifts from C. Mann(47) .

Cells were grown in mineral medium (MV, 0.67% Difco yeast nitrogen base without amino acids) containing 2% glucose or for derepression of FBPase, 2% ethanol as the carbon source, and required supplements. Radiolabeling was done in pulse medium (0.17% Difco yeast nitrogen base without amino acid and ammonium sulfate, 0.5% proline, 100 µM ammonium sulfate, 2% ethanol, and required supplements). In all experiments requiring induction of Ub synthesis, CuSO(4) was added to a final concentration of 100 µM.

Antibodies

Antibodies against FBPase were raised in rabbits using a FBPase-MS2 fusion protein expressed in E. coli(13) . Antibodies to the ha epitope (12CA5) were from Berkeley Antibody Co. Inc. Secondary peroxidase-conjugated anti mouse antibodies (anti-mouse IgG (H+L)) were from Dianova (Hamburg, Germany).

Pulse-Chase Analysis and Immunoprecipitation

Yeast strains were cultured in MV medium containing 2% glucose and required supplements until an A of 5-6 was reached. After harvesting (for 5 min at 500 times g) and washing, cells were preincubated for 3.5 h in pulse medium at an A of 3.

Radiolabeling was done by adding [S]methionine (Amersham, Braunschweig) to the cell suspension to a final concentration of 45 µCi bullet ml (pulse). After 1.5 h, cells were shifted onto MV medium containing 2% glucose and 10 mM nonradioactive methionine (chase). In the experiments overexpressing different ubiquitin derivatives, CuSO(4) (100 µM) was present during the pulse and chase periods. 1-ml samples were taken at the times indicated, and the chase was terminated by the addition of trichloroacetic acid (final concentration, 5%). The precipitates were washed twice with cold ethanol (-20 °C) and dried. Subsequently cells were lysed in 100 µl of breaking buffer (50 mM Tris, pH 7.5, 6 M urea, 1% SDS, and 1 mM EDTA) with agitation by glass beads three times for 1 min with intermittent heating at 95 °C, followed by a 5-min heating period at the same temperature. The lysate was diluted with 1 ml of IP buffer (50 mM Tris, pH 7.5, 190 mM NaCl, 6 mM EDTA, and 1.25% Triton X-100) containing protease inhibitors (1 mM PMSF and 20 µg bullet ml each of chymostatin, pepstatin A, leupeptin, and antipain), centrifuged, and transferred to a new test tube. FBPase antiserum (8 µl) was added, and the samples were gently agitated for 2 h at room temperature. Immunoprecipitates were collected by adding 50 µl of a protein A-Sepharose Cl4-B (Pharmacia, Freiburg, Germany) suspension (5% w/v in IP) and further incubated for 1 h. The Sepharose beads were centrifuged and washed three times with IP buffer. Proteins were released from Sepharose by boiling in 50-100 µl of 2 times concentrated Laemmli sample buffer (200 mM Tris/HCl, pH 6.8, 10% SDS, 20% glycerol, 0.2% bromphenol blue), separated by SDS-PAGE (10%), and visualized by fluorography. Protein bands were quantitated using a Fuji BAS 2000 bio-imaging analyzer.

Western Blot

Yeast cells transformed with Ub-encoding plasmids (YEp96, YEp110, or YEp112) were grown in MV medium containing 2% glucose until an A of 5-6. After harvesting (5 min at 500 times g), cells were resuspended in MV medium containing 2% ethanol and 100 µM CuSO(4) to an A of 5 and incubated for 5 h to derepress FBPase. After the addition of glucose (final concentration, 2%), 1-ml samples were taken at the times indicated and treated with trichloroacetic acid (final concentration, 5%). Cell lysis and immunoprecipitation with FBPase antibodies (6 µl/sample) were performed as described above. Proteins were released from the Sepharose beads by boiling in 40 µl of 2 times concentrated Laemmli sample buffer, separated by SDS-PAGE (10%), and electroblotted onto a nitrocellulose filter (Schleicher & Schuell, Dassel, Germany). The filter was blocked by gently shaking for 3 h at room temperature with PBS-T buffer (50 mM K(2)HPO(4), pH 7.4, 150 mM NaCl, and 0.1% Tween 20) containing 10% nonfat milk. Thereafter the filter was gently treated for 2 h with ha antibodies (1:5000 in PBS-T). After washing three times in PBS-T, secondary antibodies (anti-mouse IgG) were added (1:5000 in PBS-T) to the filter followed by gentle shaking for 45 min. HaUb conjugates were visualized using the ECL detection kit from Amersham (Braunschweig, Germany).


RESULTS AND DISCUSSION

Ubiquitin-mediated degradation of a protein requires the covalent attachment of ubiquitin moieties, leading to the occurrence of higher molecular mass species of such a protein. The use of an epitope-tagged ubiquitin derivative allows the unambiguous identification of such ubiquitin protein conjugates in vivo(46, 48) .

If catabolite degradation of FBPase were mediated via the ubiquitin pathway, higher molecular mass species of FBPase would be expected. When pulse-labeled FBPase was immunoprecipitated during catabolite inactivation in cells expressing wild-type ubiquitin from a 2-µm plasmid, at least two additional labeled species with higher mass than FBPase could be detected in the precipitates (Fig. 1A, lanes 2 and 3). The appearance of these larger species was only visible after shifting cells derepressed of FBPase onto glucose medium (compare Fig. 1A, lane 1 with lanes 2 and 3), suggesting that these species are intermediates of the glucose-induced degradation process of FBPase. To test whether these species actually represent ubiquitin conjugates of FBPase, a ha-tagged version of ubiquitin was overexpressed. This ubiquitin variant (haUb) is about 1.5 kDa (14 amino acids) larger than wild-type ubiquitin, resulting in a decrease of the mobility of this molecule on SDS-PAGE.


Figure 1: FBPase is ubiquitinated in vivo. A, pulse-chase analysis of FBPase degradation. In addition to FBPase, FBPase immunoprecipitates show a set of higher molecular mass species (arrows, lanes 2 and 3). Cells of W3031B overexpressing wild-type Ub were pulse-labeled during derepression of FBPase in ethanol-containing medium and chased with the addition of glucose, followed by extraction, immunoprecipitation, and SDS-PAGE as described under ``Materials and Methods.'' B, comparison of the SDS-PAGE pattern of FBPase immunoprecipitates from labeled W3031B cells expressing either wild-type ubiquitin (wt-Ub, lane 2) or haUb (lane 3). Expression of haUb in W3031B cells leads to an increase of the apparent molecular masses of the putative Ub-FBPase conjugates. FBPase null mutant (Deltafbp1) cells expressing either wild-type Ub or haUb show no corresponding ubiquitin conjugates (lanes 1 and 4). Samples were taken 20 min after the addition of glucose to the cells.



If the larger protein species present in the FBPase precipitates (Fig. 1A) were ubiquitinated forms of this enzyme, in vivo substitution of wild-type ubiquitin with haUb would lead to a slower migration of these species as compared with FBPase ligated to wild-type ubiquitin.

Cells transformed with either plasmid YEp96 expressing wild-type Ub or plasmid YEp112 expressing haUb were pulse-labeled during derepression of FBPase. After inducing the inactivation period by addition of glucose, samples were taken. Crude extracts were immunoprecipitated with FBPase antibodies, and proteins were separated by SDS-PAGE (Fig. 1B). Comparison of the pattern of bands in lanes 2 (expression of wild-type Ub) and 3 (expression of haUb) of Fig. 1B shows that in the presence of haUb the new protein species appearing are of higher molecular mass than those species appearing in the presence of wild-type Ub. This indicates that the newly appearing bands represent ubiquitinated proteins. Moreover, the absence of the corresponding bands in the control patterns obtained from FBPase null mutants also expressing either wild-type or ha-tagged Ub (Fig. 1B, lanes 1 and 4) reveals that these species are ubiquitinated forms of FBPase. To further confirm this, we tested whether the putative FBPase-ubiquitin conjugates immunoreacted with both FBPase and ha antibodies. Crude extracts from glucose-inactivated cells were immunoprecipitated with FBPase antibodies; proteins were separated by SDS-PAGE and blotted onto nitrocellulose filters. The filters were then probed with ha antibodies. As can be seen in Fig. 2, lanes 6, 7, and 8, extracts from cells expressing haUb show a complex spectrum of ha-ubiquitin-FBPase conjugates after shifting cells to glucose. The amount of ubiquitinated FBPase species is highest shortly after glucose addition (Fig. 2, lane 6), followed by a drastic decline along with further incubation of the cells on glucose (Fig. 2, lanes 7 and 8). This behavior is consistent with the view that the ubiquitinated forms of FBPase are the substrates of the degradation machinery of the cell. As expected, neither in cells expressing wild-type Ub nor in FBPase null mutant cells (Deltafbp1) expressing haUb is any ubiquitin conjugate detectable (Fig. 2, lanes 2 and 4 respectively), clearly confirming that the observed bands in Fig. 2(lanes 6-8) represent ubiquitinated forms of FBPase. From these data we conclude that FBPase is ubiquitinated upon glucose addition and that this event triggers catabolite degradation of the enzyme.


Figure 2: Immunodetection of Ub-FBPase conjugates during catabolite inactivation. Crude extracts from cells expressing either haUb or wild-type ubiquitin (wt-Ub) were immunoprecipitated with FBPase antibodies and separated by SDS-PAGE. Thereafter the proteins were transferred to a nitrocellulose membrane and probed with ha antibodies. A variety of different haUb-FBPase conjugates occur after shifting the cells onto glucose (lanes 6-8). The amount of these conjugates decline with increasing time after glucose addition. The controls (FBPase null mutant (Deltafbp1) expressing haUb and wild-type cells (FBP1) expressing wild-type Ub) display no FBPase-Ub conjugates as expected (lanes 1-4).



It has been shown that treatment of cells with cycloheximide at the time of glucose addition prevents degradation of FBPase(11) . We found that FBPase is also not ubiquitinated under these conditions (not shown). This indicates the necessity upon catabolite inactivation of the new synthesis of a protein(s) that is part of the signaling cascade and indispensible for ubiquitination and degradation of FBPase.

For the N-end rule substrates (27) and for the Matalpha2 repressor (46) it has been shown that proteolysis via the ubiquitin-mediated pathway requires formation of a multiubiquitin chain for their efficient degradation. The ubiquitin molecules are linked within this chain by isopeptide bonds connecting the carboxyl-terminal Gly of one ubiquitin moiety to the -amino group of Lys of the adjacent ubiquitin molecule. Lys and Lys have also been found to be sites for polyubiquitination(49) , but Lys has been identified as the primary site of this process. A modified ubiquitin carrying an arginine at position 48 (Ub-R48) instead of lysine can still be conjugated to other proteins but fails to function as an acceptor within the multiubiquitin chain (27) . Therefore, Ub-R48 can serve as a probe for monitoring the presence of a Lys-linked multiubiquitin chain in a protein of interest(6) .

Western blot analysis had indicated the appearance of multiply ubiquitinated FBPase molecules during catabolite inactivation (Fig. 2, lane 6). If Lys-linked multiubiquitination is a prerequisite for glucose-induced degradation of FBPase, the presence of Ub-R48 should affect this process. To address this possibility we compared the degradation rate of FBPase in cells expressing high levels of wild-type ubiquitin (transformed with YEp96) and in cells expressing high levels of Ub-R48 (transformed with YEp110) by pulse-chase analysis. Although glucose-induced degradation of FBPase occurred in cells overexpressing wild-type ubiquitin (Fig. 3A), the presence of Ub-R48 inhibited the degradation of the enzyme (Fig. 3B).


Figure 3: Overexpression of Ub-R48 inhibits glucose-induced FBPase degradation. Pulse-chase analysis in W3031B cells expressing either wild-type Ub (wt-Ub, A) or Ub-R48 (B) was done as described in the legend to Fig. 1.



It is noticeable that the expression of Ub-R48 resulted in an increase of the amount of the monoubiquitinated FBPase species (see arrow in Fig. 3). The SDS-PAGE pattern of FBPase immunoprecipitates from pulse-labeled cells expressing Ub-R48 did not show multiply ubiquitinated species of FBPase (not shown). Formation of a multiubiquitin chain containing Lys linkages seems therefore to be necessary for glucose-induced degradation of FBPase. As degradation of FBPase is nearly blocked in cells expressing Ub-R48, Lys must be viewed as the important site for polyubiquitination to render FBPase accessible to proteolysis.

Using mutants defective in subunits of the 20 S proteasome we had shown that this particle is involved in catabolite degradation of FBPase (12, 13) . In vitro studies had shown that ubiquitinated proteins are degraded by the 26 S proteasome(19, 20, 21) . To elucidate whether the 26 S complex is needed for FBPase degradation, we assayed the catabolite inactivation of the enzyme in strains carrying a temperature-sensitive mutation in the CIM3 gene, which encodes a regulatory subunit of the 26 S proteasome(47) . Cim3-1 mutant cells arrest the cell cycle at nonpermissive temperature and accumulate Ub-Pro-betagal, degradation of which is ubiquitin-dependent. Pulse-chase analysis of FBPase during glucose-induced degradation indicated that the enzyme is remarkably stabilized in cim3-1 cells relative to the isogenic wild type (Fig. 4). This documents that the entire 26 S proteasome complex is necessary for catabolite inactivation to occur.


Figure 4: Glucose-induced degradation of FBPase depends on an intact 26 S proteasome. Pulse-chase analysis of FBPase degradation in CIM3 (A) and cim3-1 (B) mutant cells was done as described in the legend to Fig. 1.



The finding that catabolite inactivation of FBPase is triggered by ubiquitination pointed to the action of E2 (Ubc) enzymes involved in this process. Therefore we measured the degradation rate of FBPase after the addition of glucose in yeast strains deleted in various UBC genes and thus devoid of the respective activitiy of the Ubc enzyme. Pulse-chase analysis indicated that catabolite degradation of FBPase was unaffected in cells lacking a functional Ubc2 (Rad6), Ubc6, Ubc7, and Ubc10 (Pas2) protein (not shown). In contrast, the degradation was strongly inhibited in ubc1 and ubc4 ubc5 mutant strains (Fig. 5A). The half-life of FBPase was increased 2-fold in ubc1 cells and 4-fold in ubc4 ubc5 double mutant cells (Fig. 5B). Single deletions of either UBC4 or UBC5 led only to a weak but reproducible increase of the half-life of FBPase during the catabolite inactivation process (25 min and 20 min, respectively, versus 17 min in wild-type cells, not shown). This behavior might have been expected, because it is conceivable that the nearly identical Ubc4 and Ubc5 enzymes are functionally redundant(28, 29) .


Figure 5: Glucose-induced degradation of FBPase depends on UBC1, UBC4, and UBC5. A, pulse-chase analysis of FBPase degradation in wild-type (wt), ubc1, ubc4, ubc5, and ubc4 ubc5 mutants was done as described in the legend to Fig. 1. B, quantitation of an independent set of pulse-chase experiments analyzing FBPase degradation in wild-type, ubc1, and ubc4 ubc5 mutants.



When measuring the degradation of FBPase by assaying enzymatic activity, similar results were obtained (not shown). It should be noted that all ubc mutants showed the characteristic rapid loss of FBPase activity of about 50% during the first 15 min of catabolite inactivation. This is due to phosphorylation of FBPase (4, 5) and indicates that the transduction of the glucose-induced signal is not impaired in the ubc mutant cells. On the basis of genetic studies, it had been shown that Ubc1, Ubc4, and Ubc5 constitute a subfamily of ubiquitin-conjugating enzymes with overlapping functions (28) . This feature is nicely reflected in the catabolite degradation process of FBPase.

Based on the above described findings we assume the following model for catabolite inactivation of FBPase. The addition of glucose to yeast cells grown on a nonfermentable carbon source causes phophorylation (4, 5) and ubiquitination of the enzyme. The formation of a multiubiquitin chain targets FBPase for degradation through the 26 S proteasome, thereby changing the half-life of the enzyme from over 90 h on ethanol (3) to under 20 min (Fig. 5B). The ubiquitin-conjugating enzymes Ubc1, Ubc4, and Ubc5 and the glucose-inducible, newly synthesized protein(s) are necessary for FBPase inactivation to occur. It seems unlikely that the glucose-induced synthesis of a new protein concerns the provision of ubiquitin-conjugating enzymes, because activities of Ubc1, Ubc4, or Ubc5 are already present under the conditions of catabolite inactivation. Ubc1 is expressed in exponentially growing cells and with enhanced levels in stationary phase cells; Ubc4 is also expressed in exponentially growing cells, and Ubc5 is present in stationary phase cells(28, 29) .

The catabolite inactivation process of FBPase represents an ideal model to follow the fate of a protein from the signaling event to ubiquitin proteasome-mediated degradation. Respective studies are on the way.


FOOTNOTES

*
This work was supported by the Deutsche Forschungsgemeinschaft and the Fonds der Chemischen Industrie. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§
To whom correspondence should be addressed: Universität Stuttgart, Institut für Biochemie, Pfaffenwaldring 55, D-70569 Stuttgart, Germany. Tel.: 49-711-6854390; Fax: 49-711-6854392.

(^1)
The abbreviations used are: FBPase, fructose-1,6-bisphosphatase; Ub, ubiquitin; Ub-R48, ubiquitin with an arginine instead of a lysine at position 48; ha, hemagglutinin; haUb, hemagglutinin epitope-tagged ubiquitin; PAGE, polyacrylamide gel electrophoresis.


ACKNOWLEDGEMENTS

We thank H.-L. Chiang, S. Jentsch, W. H. Kunau, C. Mann, and M. Hochstrasser for providing strains and plasmids.


REFERENCES

  1. Gottesman, S., and Maurizi, M. R. (1992) Microbiol. Rev. 56, 592-621 [Abstract]
  2. Holzer, H. (1976) Trends Biochem. Sci. 1, 178-181
  3. Funayama, S., Gancedo, J. M., and Gancedo, C. (1980) Eur. J. Biochem. 109, 61-66 [Abstract]
  4. Müller, D., and Holzer, H. (1981) Biochem. Biophys. Res. Commun. 103, 926-933 [Medline] [Order article via Infotrieve]
  5. Mazon, M. J., Gancedo, J. M., and Gancedo, C. (1982) J. Biol. Chem. 257, 1128-1130 [Abstract/Free Full Text]
  6. Gancedo, C. (1971) J. Bacteriol. 107, 401-405 [Medline] [Order article via Infotrieve]
  7. Molano, J., and Gancedo, C. (1974) Eur. J. Biochem. 44, 213-217 [Medline] [Order article via Infotrieve]
  8. Wolf, D. H., and Ehmann C. (1979) Eur. J. Biochem. 98, 375-384 [Abstract]
  9. Zubenko, G. S., and Jones, E. W. (1979) Proc. Natl. Acad. Sci. U. S. A. 76, 4581-4585 [Abstract]
  10. Teichert, U., Mechler, B., Müller, H., and Wolf, D. H. (1989) J. Biol. Chem. 264, 16037-16045 [Abstract/Free Full Text]
  11. Chiang, H.-L., and Schekman, R. (1991) Nature 350, 313-318 [CrossRef][Medline] [Order article via Infotrieve]
  12. Schork, S. M., Bee, G., Thumm, M., and Wolf, D. H. (1994) Nature 369, 283-284 [CrossRef][Medline] [Order article via Infotrieve]
  13. Schork, S. M., Bee, G., Thumm, M., and Wolf, D. H. (1994) FEBS Lett. 349, 270-274 [CrossRef][Medline] [Order article via Infotrieve]
  14. Rivett, A. J. (1993) Biochem. J. 291, 1-10 [Medline] [Order article via Infotrieve]
  15. Peters, J. M. (1994) Trends Biochem. Sci. 19, 377-382 [CrossRef][Medline] [Order article via Infotrieve]
  16. Heinemeyer, W., Kleinschmidt, J. A., Saidowsky, J., Escher, C., and Wolf, D. H. (1991) EMBO J. 10, 555-562 [Abstract]
  17. Richter-Ruoff, B., Heinemeyer, W., and Wolf, D. H. (1992) FEBS Lett. 302, 192-196 [CrossRef][Medline] [Order article via Infotrieve]
  18. Seufert, W., and Jentsch, S. (1992) EMBO J. 11, 3077-3080 [Abstract]
  19. Hough, R., Pratt, G., and Rechsteiner, M. (1986) J. Biol. Chem. 261, 2400-2408 [Abstract/Free Full Text]
  20. Eytan, E., Ganoth, D., Armon, T., and Hershko, A. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 7751-7755 [Abstract]
  21. Driscoll, J., and Goldberg, A. L. (1990) J. Biol. Chem. 265, 4789-4792 [Abstract/Free Full Text]
  22. Finley, D. (1992) in The Molecular and Cellular Biology of the Yeast Saccharomyces cerevisiae (Jones, E. W., Pringle, J. R., and Broach, J. R. eds) pp. 539-582, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
  23. Jentsch, S. (1992) Annu. Rev. Genet. 26, 179-207 [CrossRef][Medline] [Order article via Infotrieve]
  24. Hershko, A., and Ciechanover, A. (1992) Annu. Rev. Biochem. 61, 761-807 [CrossRef][Medline] [Order article via Infotrieve]
  25. Rechsteiner, M., Hoffman, L., and Dubiel, W. (1993) J. Biol. Chem. 268, 6065-6068 [Free Full Text]
  26. Ciechanover, A. (1994) Biol. Chem. Hoppe-Seyler 375, 565-581 [Medline] [Order article via Infotrieve]
  27. Chau, V., Tobias, J. W., Bachmair, A., Marriott, D., Ecker, D. J., Gonda, D. K., and Varshavsky, A. (1989) Science 243, 1576-1583 [Medline] [Order article via Infotrieve]
  28. Seufert, W., McGrath, J. P., and Jentsch, S. (1990) EMBO J. 9, 4535-4541 [Abstract]
  29. Seufert, W., and Jentsch, S. (1990) EMBO J. 9, 543-550 [Abstract]
  30. Sommer, T., and Jentsch, S. (1993) Nature 365, 176-179 [CrossRef][Medline] [Order article via Infotrieve]
  31. Goebl, M. G., Yochem, J., Jentsch, S., McGrath, J. P., Varshavsky, A., and Byers, B. (1988) Science 241, 1331-1335 [Medline] [Order article via Infotrieve]
  32. Seufert, W., Futcher, B., and Jentsch, S. (1995) Nature 373, 78-83 [CrossRef][Medline] [Order article via Infotrieve]
  33. Jentsch, S., McGrath, J. P., and Varshavsky, A. (1987) Nature 329, 131-134 [CrossRef][Medline] [Order article via Infotrieve]
  34. Dohmen, J., Madura, K., Bartel, B., and Varshavsky, A. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 7351-7355 [Abstract]
  35. Wiebel, F. F., and Kunau, W.-H. (1992) Nature 359, 73-76 [CrossRef][Medline] [Order article via Infotrieve]
  36. Bartel, B., Wünning, I., and Varshavsky, A. (1990) EMBO J. 9, 3179-3189 [Abstract]
  37. Chen, P., Johnson, P., Sommer, T., Jentsch, S., and Hochstrasser, M. (1993) Cell 74, 357-369 [Medline] [Order article via Infotrieve]
  38. Kornitzer, D., Raboy, B., Kulka, R. G., and Fink, G. R. (1994) EMBO J. 13, 6021-6030 [Abstract]
  39. Glotzer, M., Murray, A. W., and Kirschner, M. W. (1991) Nature 349, 132-138 [CrossRef][Medline] [Order article via Infotrieve]
  40. Deshaies, R. J., Chau, V., and Kirschner, M. (1995) EMBO J. 14, 303-312 [Abstract]
  41. Yaglom, J., Linskens, M. H. K., Sadis, S., Rubin, D. M., Futcher, B., and Finley, D. (1995) Mol. Cell. Biol. 15, 731-741 [Abstract]
  42. Scheffner, M., Huibregtse, J. M., Vierstra, R. D., and Howley, P. M. (1993) Cell 75, 495-505 [Medline] [Order article via Infotrieve]
  43. Nishiazawa, M., Furuno, N., Okazaki, K., Tanaka, H., Ogawa, Y., and Sagata, N. (1993) EMBO J. 12, 4021-4027 [Abstract]
  44. Murakami, Y., Matsufuji, S., Kameji, T., Hayashi, S., Igarashi, K., Tamura, T., Tanaka, K., and Ichihara, A. (1992) Nature 360, 597-599 [CrossRef][Medline] [Order article via Infotrieve]
  45. Mamroud-Kidron, E., Rosenberghasson, Y., and Kahana, C. (1994) FEBS Lett. 337, 239-242 [CrossRef][Medline] [Order article via Infotrieve]
  46. Hochstrasser, M., Ellison, M. J., Chau, V., and Varshavsky, A. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 4606-4610 [Abstract]
  47. Ghislain, M., Udvardy, A., and Mann, C. (1993) Nature 366, 358-362 [CrossRef][Medline] [Order article via Infotrieve]
  48. Ellison, M. J., and Hochstrasser, M. (1991) J. Biol. Chem. 266, 21150-21157 [Abstract/Free Full Text]
  49. Arnason, T., and Ellison, M. J. (1994) Mol. Cell. Biol. 14, 7876-7883 [Abstract]

©1995 by The American Society for Biochemistry and Molecular Biology, Inc.